Shandong Xinhua Pharmaceutical Company Limited

SHSC:719 Stock Report

Market Cap: HK$9.4b

Shandong Xinhua Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 719?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,946,4070.282%
Individual Insiders4,059,5500.589%
Institutions13,840,4242.01%
VC/PE Firms37,091,9885.38%
Private Companies167,772,10424.3%
General Public465,066,06267.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 32.56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.3%
Hualu Holdings. Co, Ltd
167,772,104HK$2.3b14.2%no data
5.38%
Hualu Investment Development Co., Ltd.
37,091,988HK$506.9m0%66.19%
0.4%
Dimensional Fund Advisors LP
2,783,200HK$38.0m0%no data
0.35%
China Southern Asset Management Co., Ltd.
2,422,500HK$33.1m0%0.01%
0.28%
Hong Kong Exchanges and Clearing Limited
1,946,407HK$26.6m0%no data
0.19%
The Vanguard Group, Inc.
1,311,942HK$17.9m-0.21%no data
0.19%
China Asset Management Co. Ltd.
1,296,900HK$17.7m0%no data
0.15%
Galaxy Derivatives Capital Management Co. Ltd.
1,027,330HK$14.0m0%0.33%
0.15%
GF Fund Management Co., Ltd.
1,008,830HK$13.8m0%no data
0.12%
State Street Global Advisors, Inc.
826,402HK$11.3m0.9%no data
0.12%
Kui Hu
820,500HK$11.2m0%no data
0.11%
Wanjia Asset Management Co., Ltd.
783,115HK$10.7m0%0.02%
0.11%
Zhonglin He
761,600HK$10.4m0%no data
0.11%
Shenyin Wanguo Asset Management (Asia) Limited
742,255HK$10.1m0%0.11%
0.095%
Huatai Securities (Shanghai) Asset Management Co., Ltd.
655,865HK$9.0m0%0.1%
0.089%
Everbright Asset Management Co., Ltd.
616,755HK$8.4m0%0.17%
0.063%
Ning Hou
434,400HK$5.9m32.1%no data
0.058%
Lie Xu
397,550HK$5.4m36.2%no data
0.058%
Tongqing He
397,550HK$5.4m36.2%no data
0.05%
Wenhui Xu
347,600HK$4.8m43.6%no data
0.047%
Fullgoal Fund Management Co. Ltd.
325,500HK$4.4m0%no data
0.042%
Zhonghui Zheng
291,950HK$4.0m0%no data
0.035%
Changsheng Wei
242,000HK$3.3m0%no data
0.029%
Changqiu Cao
201,200HK$2.7m0%no data
0.013%
Xuesong Liu
91,100HK$1.2m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 19:43
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shandong Xinhua Pharmaceutical Company Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ming LiIndustrial Securities Co. Ltd.
Laurence TamMorgan Stanley
Guohe FanPhillip Securities (HK)